News | May 18, 2025
Abbott India posts Q4 FY25 net profit at Rs. 367.04 Cr
The company has posted net profit of Rs. 1,414.44 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 1,414.44 crores for the Financial Year ended March 31, 2025
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages
Prithwish has close to 28 years of experience in a Commercial role
The company has reported total income of Rs. 1,693.15 crores during the period ended September 30, 2024
This license will enable Abbott to enhance access to this novel therapy to more patients across India
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024
Subscribe To Our Newsletter & Stay Updated
